foxo4-dri senolytic peptide human trial The FOXO4 in a DRI conformation (D-amino acids in a retro-reversed sequence), henceforth named FOXO4-DRI, competes with FOXO4 for p53 binding in a dose-dependent manner and doing so with higher affinity Cardiovascular Support Color:240 Light Medium BPC-157 | Wholesale Pricing

foxo4-dri senolytic peptide human trial The FOXO4 in a DRI conformation (D-amino acids in a retro-reversed sequence), henceforth named FOXO4-DRI, competes with FOXO4 for p53 binding in a dose-dependent manner and doing so with higher affinity Cardiovascular Support Color:240 Light Medium BPC-157 | Wholesale Pricing

BPC-157 | Wholesale Pricing

Research mechanism: BPC-157 has been studied for effects on: Angiogenic processes (new blood vessel formation in tissue) Tissue protection and repair Growth factor expression Various tissue contexts including gastrointestinal, cardiovascular, and musculoskeletal For longevity research specifically, BPC-157's relevance is in the tissue maintenance and repair angle — preserving tissue function over time as part of broader longevity-focused research

Cardiovascular Support

Color:240 Light Medium

The full dose is delivered straight into your system, enabling you to feel happier, vibrant and more energised